Simplexia AB is a Swedish AB based in Göteborg, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2017, the company has 2 employees and reported revenue of SEK 0 in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med suppleanterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva verifierings- och utvecklingsarbete till kommersiell exploatering av diagnostik, läkemedel och vaccin mot virussjukdomar och därmed förenlig verksamhet.
In its most recent annual report (2024), Simplexia AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of SEK 3.9m.
At the end of 2024, equity financed 85.6% of the balance sheet, and current assets covered short-term debt 2.4 times.
Frequently asked questions
What is the Org number of Simplexia AB?
Simplexia AB is registered with Bolagsverket / SCB under Org 5591061501.
How many employees does Simplexia AB have?
Simplexia AB employs 2 people as of the latest annual report.
Who is the CEO of Simplexia AB?
Nina Lindblom is the CEO of Simplexia AB, in role since 2025.
Who is the chairman of Simplexia AB?
Lena Birgitta Degling Wikingsson chairs the board of Simplexia AB, in role since 2020.
Where is Simplexia AB headquartered?
Simplexia AB's registered address is Erik Dahlbergsgatan 11 A.
